Change in healthcare resource use and associated costs of patients with metastatic lung cancer between 2013 and 2019: An observational study from the French national claims database

被引：0
|
作者：
Chouaid, C. [1 ]
Marchal, C. [2 ]
Apert, M. [3 ]
Bensimon, L. [3 ]
Guimard, V. [4 ]
Nee, M. [5 ]
Belhassen, M. [2 ]
de Pouvourville, G. [6 ]
Blay, J-Y. [7 ]
机构：
[1] CHI Ctr Hosp Intercommunal Creteil, Dept Pneumol, Creteil, France
[2] PELyon, Hlth Econ & Outcomes Res, Lyon, France
[3] MSD France, Hlth Econ & Outcomes Res, Puteaux La Defense, France
[4] MSD France, Med Affairs, Puteaux La Defense, France
[5] PELyon, Biostat, Lyon, France
[6] ESSEC Business Sch, Econ, Cergy, France
[7] Ctr Leon Berard, Dept Med, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1417P
引用
收藏
页数：1
相关论文
共 49 条
  • [41] HEALTHCARE RESOURCE UTILIZATION FOR CETUXIMAB plus CHEMOTHERAPY ADMINISTERED EVERY OTHER WEEK VS ONCE WEEKLY FOR TREATMENT OF METASTATIC COLORECTAL CANCER: REAL-WORLD OUTCOMES FROM A US CLAIMS DATABASE STUDY
    Pescott, C.
    Batech, M.
    Boutmy, E.
    Ronga, P.
    Lamy, F. X.
    VALUE IN HEALTH, 2019, 22 : S452 - S453
  • [42] Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
    Nakanishi, Miharu
    Igarashi, Ataru
    Ueda, Kaname
    Brnabic, Alan J. M.
    Treuer, Tamas
    Sato, Masayo
    Kahle-Wrobleski, Kristin
    Meguro, Kenichi
    Yamada, Masahito
    Mimura, Masaru
    Arai, Heii
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 127 - 138
  • [43] TREATMENT PATTERNS, HEALTHCARE RESOURCE USE, AND COSTS AMONG US PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATED (EGFRm) METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC) AFTER DISCONTINUATION OF OSIMERTINIB
    Moore-Schiltz, L.
    McMorrow, D.
    Chambers, J.
    Pulungan, Z.
    Teigland, C.
    Marrett, L.
    VALUE IN HEALTH, 2024, 27 (06) : S125 - S126
  • [44] Healthcare resource use and associated costs in a cohort of hospitalized COVID-19 patients in Spain: A retrospective analysis from the first to the third pandemic wave. EPICOV study
    Drago, Georgina
    Perez-Sadaba, Francisco Javier
    Aceituno, Susana
    Gari, Carla
    Lopez-Belmonte, Juan Luis
    PLOS ONE, 2023, 18 (01):
  • [45] Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study
    Castro, Franz
    Shahal, David
    Tarajia, Musharaf
    Velasquez, Ilais Moreno
    Causadias, Maribel Tribaldos
    Herrera, Victor
    Gomez, Beatriz
    Cukier, Moises
    Motta, Jorge
    BMJ OPEN, 2017, 7 (09):
  • [46] Healthcare Resource Utilization and Associated Costs among Patients with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain: A Single-Center, Real-World, Exploratory Study
    Rubio, Jorge Gines
    Delgado, Olga
    Callejo, Angel
    Dominguez, Marta
    Torres, Covadonga
    CANCERS, 2024, 16 (11)
  • [47] The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors
    Subramanian, Janakiraman
    Fernandes, Ancilla W.
    Laliberte, Francois
    Pavilack, Melissa
    DerSarkissian, Maral
    Duh, Mei Sheng
    LUNG CANCER, 2019, 138 : 131 - 138
  • [48] NON-INTERVENTIONAL REAL-WORLD EUROPEAN STUDY QUANTIFYING THE BURDEN OF CENTRAL NERVOUS SYSTEM (CNS) METASTASES ON HEALTHCARE RESOURCE USE (HRU) IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG CANCER (MNSCLC)- RESULTS FROM AN INTERIM ANALYSIS
    Crane, G.
    Khan, N.
    Pedros, M.
    Hipp, J.
    Gally, S.
    Smoljanovic, V
    Gondos, A.
    Hammerschmidt, S.
    VALUE IN HEALTH, 2017, 20 (09) : A759 - A759
  • [49] HEALTHCARE RESOURCE USE (HCRU) AND ASSOCIATED COSTS AMONG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH CAR-T CELLS IN FRANCE - A REAL-WORLD STUDY USING DATA FROM PMSI
    Di Blasi, R.
    Thieblemont, C.
    Haioun, C.
    Sala, Sackmann L.
    Mayaud, A. C.
    Diez-Andreu, P.
    Bugnard, F.
    Goguillot, M.
    Finzi, J.
    Chillotti, L.
    Benard, S.
    VALUE IN HEALTH, 2022, 25 (12) : S79 - S80
12345